NCT02814721

Brief Summary

Infiltrations from cannulation difficulties result in significant morbidity including loss of vascular access (VA) loss in hemodialysis (HD). Cannulation is reliant on personnel skill and VA characteristics. Surface marking of VA lacks real-time information and traditional ultrasound (US) devices are large, expensive and require skilled operator expertise. Sonic Window© (Analogic Ultrasound, Peabody, MA) is a coronal mode ultrasound device (CMUD) approved for VA cannulation. Study is a single center randomized, prospective pilot study comparing handheld US-guided cannulation of new arteriovenous fistula (AVF) to standard cannulation practices.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2015

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2015

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2015

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

June 21, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 28, 2016

Completed
7.7 years until next milestone

Results Posted

Study results publicly available

March 1, 2024

Completed
Last Updated

March 1, 2024

Status Verified

February 1, 2024

Enrollment Period

5 months

First QC Date

June 21, 2016

Results QC Date

December 7, 2022

Last Update Submit

February 28, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Infiltration Due to Dialysis Access Cannulation

    Infiltration is the extravasation of blood from fistula due to problems with needle insertion into fistula for dialysis.

    3 weeks from use of fistula

Secondary Outcomes (1)

  • Patient Pain Scale

    3 weeks from use of fistula

Study Arms (2)

Standard cannulation

NO INTERVENTION

The standard cannulation protocol of the center was defined as using 17 gauge needles for the first 3 dialysis sessions, followed by 16 gauge for the next 3, and finally 15 gauge for subsequent sessions.

Ultrasound guided cannulation

ACTIVE COMPARATOR

The study protocol involved similar up titration of needle size over a 3-week period, except that a pre-cannulation evaluation of the fistula was performed using the Sonic Window ultrasound device. The device was used to evaluate and identify the optimal site of cannulation (image 1). Depending upon the cannulator's preference, real-time guidance could be employed during cannulation (image 2, 3). The cannulations were performed by 4 selected personnel trained in device use and successfully completed a competency evaluation on simulator models and a mature dialysis fistula.

Device: Sonic Window ultrasound device

Interventions

Ultrasound guided cannulation

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • End-stage renal disease with new arteriovenous fistula being started for cannulation

You may not qualify if:

  • End-stage renal disease with grafts

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

GHS West pavilion dialysis center

Detroit, Michigan, 48202, United States

Location

MeSH Terms

Conditions

Arteriovenous Fistula

Condition Hierarchy (Ancestors)

Arteriovenous MalformationsVascular MalformationsCardiovascular AbnormalitiesCardiovascular DiseasesVascular FistulaVascular DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesFistulaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr. Lalathaksha Kumbar
Organization
Henry Ford Hospital

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior staff Physician

Study Record Dates

First Submitted

June 21, 2016

First Posted

June 28, 2016

Study Start

March 1, 2015

Primary Completion

August 1, 2015

Study Completion

December 1, 2015

Last Updated

March 1, 2024

Results First Posted

March 1, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations